4200 MARATHON BLVD., AUSTIN, TX
Market cap: $36.0M (12/21/2025)
Price: $0.59
Granted 180-Day Extension to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement
Reports Third Quarter Financial Results and Recent Business Highlights
Plus Therapeutics Enters Lease Agreement for New Office Space
Other Events
Files Unaudited Pro Forma Balance Sheet to Show Compliance with Nasdaq Requirement
Reports Second Quarter Financial Results and Recent Business Highlights
Submission of Matters to a Vote of Security Holders
Q3
Q2
Q1
Notice of Late Filing for Quarterly Report
Amended Annual Report
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
S-1
RW
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
PRER14A
Statement of Changes in Beneficial Ownership
Amended Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement
Correspondence